Luye Pharma Group Ltd.

HK$1.68As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2186Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (10.15%)
Div yield —
ROE 4.27%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.91
PE TTM 8.360
TSR TTM (46.66%)
Mkt cap HK$6.691B
ROIC 4.51%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.91
13.98%
(51.61%)
Hold 4|11|11|10|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.02
0.02
0.02
0.02
13.04%
21.01%
13.63%
2.24%
Revenue¥M
447.2
471.7
468.4
487.3
2.03%
9.82%
7.56%
10.42%
Peers (US$853.5M)
Cap (US$)
PE
970.0M
15.06x
852.6M
—
Capital
TTM
5Y
10Y
Leveragex
1.921
(0.050)
(0.042)
EBIT/Intx
0.271
1.363
1.271
Own earn%
(68.28)
(33.29)
(19.80)
Sh yield%
35.98
49.00
48.76
Owners
Insiders/Inst%
11.95
80.11
Short interest%
1.04
SBC / revenue%
3.78
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
14–17
$1 testx
—
Incr. ROIC%
2